ZBH
Zimmer Biomet Holdings, Inc.
$94.08
+2.74 (+3.00%)
At close · Jul 13
Market Cap
$17.61B
Shares
193,462,482
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$8.23B
+7.2%
FY2025
Net Income
$705.1M
-22%
FY2025
Gross Margin
76.02%
+0.2pp
FY2010
Operating Margin
13.34%
-3.4pp
FY2025
Diluted EPS
$3.55
-19.9%
FY2025
Operating Cash Flow
$1.7B
+13.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $8.41B | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.8B | $7.67B | — | — | — | — | — | $4.22B | $4.1B | $4.12B | $3.9B | |
| — | -$295.4M | -$292.8M | -$218M | -$201.2M | -$164.8M | -$208.4M | -$212.1M | -$226.9M | -$289.3M | -$325.3M | -$355M | — | — | — | — | — | — | — | — | — | |
| — | $2.52B | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B | $2.25B | $2.27B | $2.13B | $2.38B | $1.8B | $1.24B | $1.27B | $1.13B | $1.12B | $1.01B | $990.7M | $997.3M | $875.9M | |
| — | $4.3B | — | — | — | — | — | — | — | — | — | — | — | $3.42B | $3.34B | $3.35B | $3.33B | $3.21B | $3.1B | $3.12B | $3.02B | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 76.02% | 75.81% | 75.8% | 77.53% | |
| — | $451.3M | $458.5M | $437.4M | $458.7M | $406M | $435.8M | $322.8M | $449.3M | $391.7M | $369.9M | $365.6M | $268.8M | $187.4M | $203M | $225.6M | $238.4M | $218.5M | $205.7M | $192.3M | $182.6M | |
| — | $3.35B | $3.26B | $2.93B | $2.84B | $2.76B | $2.84B | $2.71B | $3.34B | $3.38B | $3.1B | $2.94B | $2.28B | $1.75B | $1.75B | $1.81B | $1.83B | $1.76B | $1.73B | $1.7B | $1.52B | |
| — | $677M | $665.9M | $591.9M | $561.5M | $526.8M | $529.5M | $512.1M | $584.3M | $595.9M | $603.9M | $565.9M | $337.4M | $92.5M | $78.5M | $97.1M | $93.8M | $92.3M | $93.2M | — | — | |
| — | $1.11B | $1.09B | $996.3M | $951.7M | $926.4M | $937.7M | $898.4M | $1.01B | $1.04B | $1.06B | $1.04B | $712.4M | $375.8M | $358.5M | $363.1M | $359.9M | $340.2M | $337.4M | $275.1M | $230M | |
| — | — | — | — | — | — | $32.1M | — | — | — | $17.3M | $90.7M | $196M | — | — | — | — | — | — | — | — | |
| — | $6.76B | — | — | — | — | — | — | — | — | — | — | $5.53B | $3.64B | $3.55B | $2.3B | $2.31B | $2.29B | $2.09B | $2.03B | $1.89B | |
| — | $7.23B | $7.13B | $6.39B | $6.12B | $6.24B | $5.97B | $6.04B | $6.84B | $7.9B | $7B | $6.85B | $5.53B | $3.64B | — | — | — | — | — | — | — | |
| — | $1.18B | $1.1B | $1.29B | $1.28B | $696.3M | $860.3M | $83.1M | $1.14B | $33.8M | $799.3M | $821.1M | $467.3M | $1.04B | $1.07B | $1.05B | $1.02B | $916.7M | $1.02B | $1.09B | $1.13B | |
| — | — | 13.34% | 16.74% | 17.28% | 10.03% | 12.6% | 1.36% | 14.25% | 0.43% | 10.24% | 10.71% | — | — | — | — | — | 21.72% | 24.88% | 26.45% | 28.93% | |
| — | $2.29B | $2.19B | $2.28B | $2.23B | $1.62B | $1.8B | $981.5M | $2.14B | $1.07B | $1.86B | $1.86B | $1.18B | $1.41B | $1.43B | $1.41B | $1.38B | $1.26B | $1.36B | $1.37B | $1.36B | |
| — | $3.1M | — | — | — | — | — | — | — | — | $2.2M | $2.9M | $9.4M | $11.9M | $15.6M | $15.6M | $10.1M | $3.7M | $1.8M | — | — | |
| — | $19.6M | $25.5M | -$31.1M | -$9.3M | -$128M | $12.2M | $23.8M | -$4.8M | -$15.6M | -$9.4M | -$66.5M | -$36.9M | -$46.7M | — | — | — | — | — | — | — | |
| — | — | $14.7M | -$42.1M | -$18.5M | -$116.6M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $903.1M | $830.8M | $1.04B | $1.07B | $403.5M | $499M | -$105.2M | $905.8M | -$271.1M | $464.6M | $399.6M | $153.2M | $939.4M | $1.01B | $990.1M | $978.9M | $860.2M | $998.2M | $1.12B | $1.13B | |
| — | $142.2M | $125.7M | $131.4M | $42.2M | $112.3M | $53.5M | -$96M | -$225.7M | $108.2M | -$1.35B | $95M | $7M | $220.2M | $229.5M | $237.2M | $218.9M | $263.3M | $280.8M | $272.3M | $357.9M | |
| — | $761.2M | $705.1M | $903.8M | $1.02B | $231.4M | $401.6M | -$138.9M | $1.13B | -$379.2M | $1.81B | $305.9M | $147M | $720.3M | $780.4M | $755M | $760.8M | $596.9M | $717.4M | $848.6M | $773.2M | |
| — | — | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% | -2.27% | 14.18% | -4.78% | 23.24% | 3.99% | — | — | — | — | — | 14.14% | 17.52% | 20.59% | 19.84% | |
| — | — | — | — | — | — | $500K | $1.5M | -$100K | -$100K | -$400K | -$1.3M | -$800K | -$1.1M | -$1.8M | -$2.1M | -$800K | — | $0 | $900K | $500K | |
| — | $858.1M | $762.2M | $832M | $1.01B | $222.6M | $467.8M | -$194.8M | $1.08B | -$440.5M | $2.17B | $200.1M | -$220.6M | $457.4M | $813.2M | $827.6M | $711.3M | $559.3M | $836M | $798.3M | $854.3M | |
| USD/shares | — | — | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | -$0.67 | $5.36 | -$1.81 | $8.72 | $1.49 | $0.76 | $4.14 | $4.47 | $4.19 | $3.93 | $2.89 | $3.24 | $3.62 | $3.18 |
| USD/shares | $8.40 – $8.55* | — | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | -$0.67 | $5.31 | -$1.81 | $8.64 | $1.47 | $0.75 | $4.08 | $4.41 | $4.17 | $3.91 | $2.88 | $3.22 | $3.61 | $3.17 |
| shares | — | — | 198M | 203.1M | 208.7M | 209.6M | 208.6M | 207M | 211.25M | 209.61M | 207.96M | 206M | 193.02M | 174.07M | 174.69M | 180.15M | 193.23M | 206M | 221.45M | 234.12M | 242.57M |
| shares | — | — | 198.7M | 203.9M | 209.7M | 210.3M | 210.4M | 207M | 212.9M | 209.61M | 209.81M | 208.47M | 195.49M | 176.85M | 176.95M | 181.28M | 194.36M | 207.13M | 222.27M | 235.15M | 244.63M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $8.14B in buybacks, $2.49B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.93×
Medical Devices median 2.41×
EV/EBIT
20.91×
Medical Devices median 21.20×
P/E (TTM)
23.58×
Medical Devices median 26.62×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Americas | $5,144,600,000 | $4,794,800,000 | $4,624,100,000 | $4,295,500,000 | $4,102,100,000 | $3,699,500,000 | $4,875,800,000 | $4,837,200,000 |
| EMEA | $1,828,800,000 | $1,691,100,000 | $1,592,400,000 | $1,456,500,000 | $1,477,200,000 | $1,237,300,000 | $1,746,900,000 | $1,801,900,000 |
| Asia Pacific | $1,258,100,000 | $1,192,800,000 | $1,177,700,000 | $1,187,800,000 | $1,248,000,000 | $1,190,700,000 | $1,359,500,000 | $1,293,800,000 |
| United States | — | $4,439,000,000 | $4,288,800,000 | — | $3,853,900,000 | $3,507,700,000 | $4,592,100,000 | $4,560,000,000 |
| Non Us | — | $3,239,600,000 | $3,105,400,000 | — | — | — | — | — |
| Americas and Global Businesses | — | — | — | — | — | $4,479,000,000 | $5,035,300,000 | $5,000,400,000 |
| Americas Orthopedics | — | — | — | — | $4,102,100,000 | $3,699,500,000 | $4,148,800,000 | — |
| Americas Spine and Global Dental | — | — | — | — | $882,000,000 | $779,500,000 | $886,500,000 | — |
| Immaterial Product Category Operating Segments | — | — | — | — | — | — | $1,168,500,000 | $1,187,300,000 |
| Others Countries | — | $3,239,600,000 | $3,105,400,000 | — | $2,973,400,000 | $2,619,800,000 | — | — |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Knees | $3,322,300,000 | $3,173,500,000 | $3,038,400,000 | $2,778,300,000 | $2,647,900,000 | $2,378,300,000 | $2,780,600,000 | $2,773,700,000 |
| SET | $2,150,200,000 | $1,865,700,000 | $1,752,600,000 | $1,696,700,000 | $1,727,800,000 | $1,525,600,000 | $1,652,500,000 | $1,401,200,000 |
| Hips | $2,093,500,000 | $1,999,100,000 | $1,967,200,000 | $1,894,900,000 | $1,856,100,000 | $1,750,500,000 | $1,931,500,000 | $1,918,900,000 |
| Technology and Data, Bone Cement and Surgical | $665,600,000 | $640,300,000 | $636,000,000 | $570,000,000 | — | — | — | — |
| Dental and Spine | — | — | — | — | — | — | $1,021,800,000 | — |
| Dental Spine and CMFT | — | — | — | — | — | — | — | $1,175,100,000 |
| Other Product Category | — | — | — | — | $595,500,000 | $473,100,000 | $595,800,000 | $664,000,000 |
Key facts
CIK
1136869
CUSIP
98956P102
13F (30d)
85 filings
60 filers
Visit website
Investor relations